AV9: TIVOZANIB
AV9 is a Ligand Of Interest in 8BEM designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 8BEM_AV9_D_401 | 49% | 47% | 0.186 | 0.933 | 0.95 | 1.11 | 2 | 2 | 0 | 0 | 100% | 1 |
| 8BEM_AV9_A_401 | 44% | 48% | 0.189 | 0.915 | 0.88 | 1.13 | 2 | 3 | 1 | 0 | 100% | 1 |
| 8BEM_AV9_G_401 | 43% | 49% | 0.191 | 0.917 | 0.83 | 1.13 | 2 | 2 | 1 | 0 | 100% | 1 |
| 8BEM_AV9_B_401 | 43% | 48% | 0.192 | 0.918 | 0.93 | 1.08 | 2 | 6 | 0 | 0 | 100% | 1 |
| 4ASE_AV9_A_3169 | 79% | 28% | 0.098 | 0.943 | 1.78 | 1.13 | 9 | 2 | 1 | 0 | 100% | 1 |
